FBXO7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.144400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.688200E-01
Normal-vs-Stage2
1.374420E-01
Normal-vs-Stage3
1.236350E-01
Normal-vs-Stage4
5.029800E-02
Stage1-vs-Stage2
4.460800E-01
Stage1-vs-Stage3
2.912200E-01
Stage1-vs-Stage4
8.142200E-01
Stage2-vs-Stage3
2.795200E-01
Stage2-vs-Stage4
7.309600E-01
Stage3-vs-Stage4
3.415000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.105000E-01
Normal-vs-AfricanAmerican
3.215200E-01
Normal-vs-Asian
9.772000E-02
Caucasian-vs-AfricanAmerican
4.941800E-01
Caucasian-vs-Asian
6.856200E-01
AfricanAmerican-vs-Asian
2.971600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.956190E-01
Normal-vs-Female
2.432800E-01
Male-vs-Female
2.628400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.498500E-03
Normal-vs-Age(41-60Yrs)
2.076400E-01
Normal-vs-Age(61-80Yrs)
2.375800E-01
Normal-vs-Age(81-100Yrs)
5.917800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.520000E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.773000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.212600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.848000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.185500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.315600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.170000E-02
Normal-vs-Daily Drinker
1.757050E-01
Normal-vs-Weekly Drinker
2.067800E-01
Normal-vs-Occasional Drinker
6.348400E-01
Normal-vs-Social Drinker
1.044810E-01
Non Drinker-vs-Daily Drinker
5.812600E-01
Non Drinker-vs-Weekly Drinker
4.239400E-01
Non Drinker-vs-Occasional Drinker
7.921000E-03
Non Drinker-vs-Social Drinker
1.578990E-01
Daily Drinker-vs-Weekly Drinker
8.040200E-01
Daily Drinker-vs-Occasional Drinker
7.118000E-02
Daily Drinker-vs-Social Drinker
4.920000E-01
Weekly Drinker-vs-Occasional Drinker
1.522790E-01
Weekly Drinker-vs-Social Drinker
6.908200E-01
Occasional Drinker-vs-Social Drinker
1.919600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.117000E-01
Normal-vs-Grade 2
8.849000E-01
Normal-vs-Grade 3
9.143600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.896200E-01
Grade 1-vs-Grade 3
9.664000E-01
Grade 1-vs-Grade 4
9.117000E-01
Grade 2-vs-Grade 3
4.259400E-01
Grade 2-vs-Grade 4
8.849000E-01
Grade 3-vs-Grade 4
9.143600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.433350E-01
Normal-vs-NonDiabetic
2.215200E-01
Diabetic-vs-NonDiabetic
4.429200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.157000E-01
Normal-vs-NoPancreatitis
1.971020E-01
Pancreatitis-vs-NoPancreatitis
4.427400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.732000E-01
Normal-vs-N1
1.634760E-01
N0-vs-N1
5.174800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.943200E-01
Normal-vs-TP53-NonMutant
4.078200E-01
TP53-Mutant-vs-TP53-NonMutant
9.310000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
